Mario Brosch

Mario Brosch

Auto-generated profile, based on publicly available information

Mario Brosch

Department of Medicine I, Gastroenterology and Hepatology, University Hospital Carl-Gustav-Carus, Technische Universität Dresden (TU Dresden), Dresden, Germany

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2016 in Nature
Verified
Journal Article
Open access
PDF file
SWSimone Wahl
Simone Wahl
ADAlexander Drong
Alexander Drong
BLBenjamin Lehne
Benjamin Lehne
MLMarie Loh
Marie Loh
WSWilliam R. Scott
William R. Scott
JCJohn C. Chambers
John C. Chambers
A large-scale epigenome-wide association study identifies changes in DNA methylation associated with body mass index in blood and adipose tissue, and correlates DNA methylation sites with high risk of incident type 2 diabetes. Obesity is a major risk factor for type 2 diabetes and related metabolic disorders. Genetic association studies have identified genomic loci associated with obesity, and recent studies have also suggested associations with DNA methylation. These authors report an epigenome-wide association study for body mass index (BMI), identifying an association with DNA methylation at 187 loci in blood and adipose tissue. They find that these methylation changes are secondary to adiposity and are also associated with an increased risk of developing type 2 diabetes, independent of conventional risk factors. Approximately 1.5 billion people worldwide are overweight or affected by obesity, and are at risk of developing type 2 diabetes, cardiovascular disease and related metabolic and inflammatory disturbances1,2. Although the mechanisms linking adiposity to associated clinical conditions are poorly understood, recent studies suggest that adiposity may influence DNA methylation3,4,5,6, a key regulator of gene expression and molecular phenotype7. Here we use epigenome-wide association to show that body mass index (BMI; a key measure of adiposity) is associated with widespread changes in DNA methylation (187 genetic loci with P < 1 × 10−7, range P = 9.2 × 10−8 to 6.0 × 10−46; n = 10,261 samples). Genetic association analyses demonstrate that the alterations in DNA methylation are predominantly the consequence of adiposity, rather than the cause. We find that methylation loci are enriched for functional genomic features in multiple tissues (P < 0.05), and show that sentinel methylation markers identify gene expression signatures at 38 loci (P < 9.0 × 10−6, range P = 5.5 × 10−6 to 6.1 × 10−35, n = 1,785 samples). The methylation loci identify genes involved in lipid and lipoprotein metabolism, substrate transport and inflammatory pathways. Finally, we show that the disturbances in DNA methylation predict future development of type 2 diabetes (relative risk per 1 standard deviation increase in methylation risk score: 2.3 (2.07–2.56); P = 1.1 × 10−54). Our results provide new insights into the biologic pathways influenced by adiposity, and may enable development of new strategies for prediction and prevention of type 2 diabetes and other adverse clinical consequences of obesity.

13 October 2014 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
SHSteve Horvath
Steve Horvath
WEWiebke Erhart
Wiebke Erhart
MBMario Brosch
Mario Brosch
OAOle Ammerpohl
Ole Ammerpohl
WSWitigo von Schönfels
Witigo von Schönfels
JHJochen Hampe
Jochen Hampe
Because of the dearth of biomarkers of aging, it has been difficult to test the hypothesis that obesity increases tissue age. Here we use a novel epigenetic biomarker of aging (referred to as an “epigenetic clock”) to study the relationship between high body mass index (BMI) and the DNA methylation ages of human blood, liver, muscle, and adipose tissue. A significant correlation between BMI and epigenetic age acceleration could only be observed for liver (r = 0.42, P = 6.8 × 10−4 in dataset 1 and r = 0.42, P = 1.2 × 10−4 in dataset 2). On average, epigenetic age increased by 3.3 y for each 10 BMI units. The detected age acceleration in liver is not associated with the Nonalcoholic Fatty Liver Disease Activity Score or any of its component traits after adjustment for BMI. The 279 genes that are underexpressed in older liver samples are highly enriched (1.2 × 10−9) with nuclear mitochondrial genes that play a role in oxidative phosphorylation and electron transport. The epigenetic age acceleration, which is not reversible in the short term after rapid weight loss induced by bariatric surgery, may play a role in liver-related comorbidities of obesity, such as insulin resistance and liver cancer. Significance Because obese people are at an increased risk of many age-related diseases, it is a plausible hypothesis that obesity increases the biological age of some tissues and cell types. However, it has been difficult to detect such an accelerated aging effect because it is unclear how to measure tissue age. Here we use a recently developed biomarker of aging (known as “epigenetic clock”) to study the relationship between epigenetic age and obesity in several human tissues. We report an unexpectedly strong correlation between high body mass index and the epigenetic age of liver tissue. This finding may explain why obese people suffer from the early onset of many age-related pathologies, including liver cancer.

1 August 2013 in Cell Metabolism
Verified
Journal Article
Closed access
MAMarkus Ahrens
Markus Ahrens
OAOle Ammerpohl
Ole Ammerpohl
WSWitigo von Schönfels
Witigo von Schönfels
JKJulia Kolarova
Julia Kolarova
SBSusanne Bens
Susanne Bens
JHJochen Hampe
Jochen Hampe

19 October 2015 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
SBStephan Buch
Stephan Buch
FSFelix Stickel
Felix Stickel
ETEric Trépo
Eric Trépo
MWMichael Way
Michael Way
AHAlexander Herrmann
Alexander Herrmann
JHJochen Hampe
Jochen Hampe

15 July 2007 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
SBStephan Buch
Stephan Buch
CSClemens Schafmayer
Clemens Schafmayer
HVHenry Völzke
Henry Völzke
CBChristian Becker
Christian Becker
AFAndre Franke
Andre Franke
JHJochen Hampe
Jochen Hampe

9 August 2012 in Genome Research
Verified
Journal Article
Open access
PDF file
CFClaudia Fritsch
Claudia Fritsch
AHAlexander Herrmann
Alexander Herrmann
MNMichael Nothnagel
Michael Nothnagel
KSKarol Szafranski
Karol Szafranski
KHKlaus Huse
Klaus Huse
MBMario Brosch
Mario Brosch
So far, the annotation of translation initiation sites (TISs) has been based mostly upon bioinformatics rather than experimental evidence. We adapted ribosomal footprinting to puromycin-treated cells to generate a transcriptome-wide map of TISs in a human monocytic cell line. A neural network was trained on the ribosomal footprints observed at previously annotated AUG translation initiation codons (TICs), and used for the ab initio prediction of TISs in 5062 transcripts with sufficient sequence coverage. Functional interpretation suggested 2994 novel upstream open reading frames (uORFs) in the 5′ UTR, 1406 uORFs overlapping with the coding sequence, and 546 N-terminal protein extensions. The TIS detection method was validated on the basis of previously published alternative TISs and uORFs. Among primates, TICs in newly annotated TISs were significantly more conserved than control codons, both for AUGs and near-cognate codons. The transcriptome-wide map of novel candidate TISs derived as part of the study will shed further light on the way in which human proteome diversity is influenced by alternative translation initiation and regulation.